These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1754336)

  • 21. Minimal change nephrotic syndrome.
    Almeida AF; Chafekar DS
    J Assoc Physicians India; 1993 May; 41(5):257-8. PubMed ID: 8300452
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids.
    Cade R; Mars D; Privette M; Thompson R; Croker B; Peterson J; Campbell K
    Arch Intern Med; 1986 Apr; 146(4):737-41. PubMed ID: 3963956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine treatment of nephrotic syndrome in children.
    Brodehl J; Hoyer PF; Oemar BS; Helmchen U; Wonigeit K
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):269-74. PubMed ID: 3381282
    [No Abstract]   [Full Text] [Related]  

  • 24. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term follow-up of the effectiveness of cyclophosphamide in corticodependent and corticoresistant infantile nephrosis. 282 cases treated in an 8-year period].
    Forese S; Tamborino G; Genova R
    Minerva Pediatr; 1977 Mar; 29(8):547-50. PubMed ID: 865435
    [No Abstract]   [Full Text] [Related]  

  • 26. [Possibilities for treating patients with the idiopathic nephrotic syndrome].
    Belovezhdov N
    Vutr Boles; 1985; 24(4):55-63. PubMed ID: 4072170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observations on the "minimal change" lesion: adult onset patients and results of cyclophosphamide treatment in children.
    Cameron JS; Ogg CS; White RH
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():211-6. PubMed ID: 4536423
    [No Abstract]   [Full Text] [Related]  

  • 28. Primary nephrotic syndrome in the elderly.
    Ponticelli C; Passerini P; Como G; Melis P; Viganò E; Pozzi C; Altieri P
    Contrib Nephrol; 1993; 105():33-7. PubMed ID: 8252869
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurotoxicity of Cyclosporine A in therapy of steroid resistant nephrotic syndrome in a 10-year old boy.
    Kwinta-Rybicka J; Ogarek I; Sancewicz-Pach K
    Przegl Lek; 1996; 53(4):369-70. PubMed ID: 8711194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease.
    Ramachandran R; Kumar D A P; Nada R; Jha V; Gupta KL; Kohli HS
    Nephrology (Carlton); 2015 May; 20(5):384-5. PubMed ID: 25872662
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
    Branten AJ; Wetzels JF
    Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2832-8. PubMed ID: 10065257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An in vitro steroid sensitivity test: antibody-dependent cellular cytotoxicity (ADCC) reaction of peripheral lymphocytes in children with nephrotic syndrome.
    Petri I; László A; Bodrogi T
    Acta Paediatr Hung; 1985; 26(3):247-53. PubMed ID: 4084413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synchronization of plasmapheresis and pulse therapy in the complex treatment of children with highly active glomerulonephritis].
    Kartasheva VI; Donov GI; Fomenko TM; Klimov IuV; Osminina MK
    Pediatriia; 1991; (7):69-74. PubMed ID: 1754331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [T-cell lymphoma under immunosuppressive treatment in minimal change glomerulopathy with nephrotic syndrome].
    Späth M; Schollmeyer P
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1161-4. PubMed ID: 7656849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term steroid-immunosuppressive treatment of the childhood nephrotic syndrome.
    Pachioli R; Genova R
    Pediatrics; 1971 Apr; 47(4):731-6. PubMed ID: 4326172
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
    Rocha H; Vaccaro Torres CE; Lessa I; Azevêdo Vinhaes L
    Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
    Barratt TM; Bercowsky A; Osofsky SG; Soothill JF
    Lancet; 1975 Jan; 1(7898):55-8. PubMed ID: 46019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of steroid resistant nephrotic syndrome in children.
    Kari JA; Halawani M
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):484-7. PubMed ID: 20427873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus statement on management of steroid sensitive nephrotic syndrome.
    Indian Pediatric Nephrology Group, Indian Academy of Pediatrics
    Indian Pediatr; 2001 Sep; 38(9):975-86. PubMed ID: 11568373
    [No Abstract]   [Full Text] [Related]  

  • 40. [Verification of indications for kidney biopsy in children with steroid-dependent nephrotic syndrome].
    Idczak-Nowicka E; Ksiazek J; Kryński J; Wyszyńska T
    Pediatr Pol; 1996 Aug; 71(8):679-83. PubMed ID: 8927471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.